key: cord-0717627-1jkilj6r authors: Ullah, Muneeb; Wahab, Abdul; Saeed, Sumbul; Khan, Shahid Ullah; Ali, Haider; Humayun, Shah; Abbasi, Banzeer Ahsan; Saud, Shah; Naveed, Khalid; Khan, Sher Aslam; Fahad, Shah title: Coronavirus and its Terrifying Inning around the Globe: The Pharmaceutical Cares at the main Frontline date: 2021-02-16 journal: Chemosphere DOI: 10.1016/j.chemosphere.2021.129968 sha: 8127e655faa58d004a365f457c9aa84122d5a4bc doc_id: 717627 cord_uid: 1jkilj6r A novel coronavirus (2019-nCoV) is an acute life-threatening disease, emerged in China, which imposed a potentially immense toll in terms of public health emergency due to high infection rate and has a devastating economic impact that attracts the world’s attention. After that, on 30 January 2020, it was officially declared as a global pandemic by World Health Organization (WHO). The International Committee on Taxonomy of Viruses (ICTV) recognized it as a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and the disease named Coronavirus Disease-19 (COVID-19). Several studies have been ameliorated the active role of COVID-19 transmission, etiology, pathogenicity, and mortality rate as serious impact on human life. The symptoms of this disease may include fever, fatigue, cough and some peoples are severely prone to gastrointestinal infection. The elderly and seriously affected peoples are likely concerned with serious outcomes. In this review, we mainly aimed to provide a benchmark summary of the silent characteristics and findings of some candidates for antiviral drugs and immunotherapies such as plasma therapy, cytokine therapy, antibodies, intravenous immunoglobulin, and pharmaceutical health concerns that are related to this disease. Novel-Coronavirus-2019 (2019-nCoV) belongs to a large family of coronaviruses 28 (CoVs), which mainly affect the respiratory system of human-beings and produced pneumonia- CoVs have reservoirs in birds (Cascella et al., 2020) . 94 Coronaviruses affect the major organs of the human body like respiratory, hepatic, 95 gastrointestinal, and nervous systems, respectively. While 5-10% of the infected cases severely 96 affected the respiratory system. It was also estimated that only 2% of people were healthy 97 carriers . The variants of the coronaviruses such as HCoV-NL63, HCoV-98 OC43, HCoV-HKU1, and HCoV-229E are commonly found in human viruses. In The common symptoms include high-grade fever, cough, and body aches (Poutanen et 127 al., 2003) . In children, it may cause flu-like symptoms. And people who become severely ill 128 suffer from shortness of breath, respiratory distress syndrome, and respiratory failure, 129 respectively. Additionally, due to the lack of oxygen supply, most of the organs of the body The symptoms appeared after the incubation period of 5 days during the infection (Li et 133 al., 2020b). The period from onset death in between 6-41 days (median=14days). The mentioned 134 period is influenced by the age and immune system of the affected patient. Therefore, the higher 135 the age usually 70 or above, the shorter will be period, and vice versa (Wang et al., 2020d) . Common symptoms of COVID-19 that appeared at the onset are hyperthermia, dry cough (when 137 an infection is in the upper respiratory tract), and myalgia, respectively. Other symptoms include 138 diarrhea, headache, dyspnea, and lymphopenia, respectively. The schematic representation of 139 systematic and respiratory disorders is shown in (Fig. 2) . The productive cough starts when the replications are presented in (Fig. 3) . (Organization, 2020c) . Furthermore, in the countries where 300 either the IPC is absent or if present but with limited scope, then it is mandatory to fulfil the 301 minimum requirements for it (Organization, 2020d) . Following are the strategies of the IPC to minimized the transmission in healthcare setups: The following are the two approaches for hand hygiene. When the infected patients are recovered, then they are advised to go to quarantine at their 433 homes because their immunity is compromised (房晓伟 et al., 2020) . In quarantine period, (Table. 2). • After the transfusion, four patients were fully recovered from ARDS within 12 days, and 613 three patients were removed from ventilators within two weeks of treatment. The following is the criteria to obtain authorization for use of convalescent plasma: • For an emergency condition such as when the response is required in less than 4 hours, The investigation regarding the use of NSAIDs in COVID-19 patients is being carried out 657 by the FDA. Useful concern for potential worsening of COVID-19 symptoms has been 658 suggested, but confirmatory clinical data is lacking at this time (Loutfy et al., 2003) . In a letter, it 659 has been suggested that the use of Ibuprofen may enhance the number of ACE2 receptors at Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the 718 viral polymerase and the proofreading exoribonuclease Chloroquine analogs as antimalarial candidates with potent in vitro 721 and in vivo activity Pharmacological and non-pharmacological efforts at 723 prevention, mitigation, and treatment for COVID-19 Anti-inflammatory effects of macrolides-an underappreciated benefit in the 725 treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary 726 conditions Treatment of Middle East respiratory syndrome with a combination of 729 lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial Macrolides in critically ill patients with Middle East 733 Respiratory Syndrome Anticipating the "Second Wave" of Health Care Strain in the COVID-19 Pandemic American College of Cardiology Foundation Washington DC Epidemiological, demographic, and clinical 738 characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a 739 descriptive study COVID-19 & Effectiveness towards it's 741 available treatment Emerging Treatments for Non-infectious Uveitis The novel Chinese coronavirus (2019-nCoV) 746 infections: Challenges for fighting the storm Azithromycin 748 attenuates airway inflammation in a mouse model of viral bronchiolitis Activation of the SARS coronavirus spike 750 protein via sequential proteolytic cleavage at two distinct sites Pneumonia 752 of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel Active monitoring of persons exposed to patients with confirmed 755 COVID-19-United States Second wave COVID-19 pandemics in Europe: a temporal 757 playbook Human 759 immunopathogenesis of severe acute respiratory syndrome (SARS) COVID-19 761 Disease due to SARS-CoV-2 (Novel Coronavirus) Features, evaluation and 763 treatment coronavirus (COVID-19). Statpearls Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with 766 atypical pneumonia after visiting Wuhan Interspecies transmission and 768 emergence of novel viruses: lessons from bats and birds A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating 771 person-to-person transmission: a study of a family cluster Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal 774 pneumonia in SARS-CoV-infected mice IFN-I response timing relative to virus 777 replication determines MERS coronavirus infection outcomes Pathogenic human coronavirus infections: causes and 779 consequences of cytokine storm and immunopathology Convalescent plasma as a potential therapy for COVID-19. The 782 Epidemiological and genetic correlates of severe acute respiratory syndrome 785 coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan Emerging coronaviruses: genome structure, replication, and 788 pathogenesis 790 Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings Lopinavir/ritonavir SARS and MERS: recent 794 insights into emerging coronaviruses Outbreak of a novel coronavirus Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab 798 in patients with rheumatoid arthritis 800 Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection Are patients with hypertension and diabetes mellitus at 803 increased risk for COVID-19 infection? The Lancet Investigational New Drug (IND) or Device 805 Exemption (IDE) Process (CBER) Breakthrough: Chloroquine phosphate has shown apparent efficacy in 807 treatment of COVID-19 associated pneumonia in clinical studies Hydroxychloroquine and azithromycin as a treatment of COVID-19: 810 results of an open-label non-randomized clinical trial Quinoline-based 813 antimalarial drugs: a novel class of autophagy inhibitors 815 Clinical characteristics of coronavirus disease 2019 in China Clinical characteristics of coronavirus disease 2019 in China Association of human 820 leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first 824 step in understanding SARS pathogenesis Early spread of COVID-19 in Romania: imported cases 826 from Italy and human-to-human transmission networks Community pharmacists' 828 knowledge and preparedness to participate in the fight against Coronavirus disease Clinical 833 features of patients infected with 2019 novel coronavirus in Wuhan A family cluster of SARS-CoV-2 infection 835 involving 11 patients in Nanjing A 837 comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy CD209L (L-SIGN) is a receptor for severe 841 acute respiratory syndrome coronavirus A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) 844 infected pneumonia (standard version) A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus 847 (2019-nCoV) infected pneumonia Mechanisms of action and clinical application of macrolides as 849 immunomodulatory medications Association of human leukocyte antigen class II alleles with severe acute 852 respiratory syndrome in the Vietnamese population Asymptomatic and presymptomatic SARS-CoV-2 infections in 855 residents of a long-term care skilled nursing facility Trilogy of ACE2: A 857 peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported 861 confirmed cases: estimation and application A major outbreak of severe acute respiratory syndrome in Hong Kong Emerging threats from zoonotic 866 coronaviruses-from SARS and MERS to CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. 868 295 Profile of specific antibodies to the SARS-associated 870 coronavirus 2020a. Potential antiviral therapeutics for 2019 Novel Coronavirus Zhonghua jie he he hu xi za zhi= Zhonghua jiehe he huxi zazhi= Chinese journal of tuberculosis and 873 respiratory diseases 43 2020b. Early transmission dynamics in Angiotensin-converting enzyme 2 is a functional receptor for 878 the SARS coronavirus Analysis of 880 epidemiological and clinical features in older patients Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the 884 application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by 885 quantitative RT-PCR Potential presymptomatic transmission of SARS-CoV-2, Zhejiang province, 887 China 889 Community transmission of severe acute respiratory syndrome coronavirus 2 2020b. 891 Viral dynamics in mild and severe cases of COVID-19 Vademecum for the treatment of people with COVID-2.0 Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a 896 preliminary study Outbreak of pneumonia of unknown etiology in 898 Wuhan, China: The mystery and the miracle Drug treatment options for the 2019-new coronavirus (2019-nCoV) 2020. 901 Perspectives on Cardiopulmonary Critical Care for Patients With COVID-19: From Members of the 902 American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation DoD COVID-19 Practice Management Guide: Clinical Management of 905 COVID-19. Defense Health Agency Falls Church United States COVID-19 experimental therapies and TdP risk MERS-CoV and H5N1 influenza virus 909 antagonize antigen presentation by altering the epigenetic landscape Host cell entry of Middle East respiratory syndrome 911 coronavirus after two-step, furin-mediated activation of the spike protein Comparative and kinetic analysis of viral shedding and immunological responses in MERS 914 patients representing a broad spectrum of disease severity The extent of transmission of novel coronavirus in Wuhan, China, 2020. 917 Multidisciplinary Air, surface 919 environmental, and personal protective equipment contamination by severe acute respiratory 920 syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient How to put on and take off personal protective equipment (PPE) Infection prevention and control of epidemic-and pandemic-prone acute 924 respiratory infections in health care. World Health Organization Decontamination and reprocessing of medical devices for health-care 926 facilities Coronavirus disease 2019 (COVID-19): situation report Coronavirus disease (covid-19) advice for the public: when and how to use 929 masks Guidelines on Core Components of Infection Prevention and Control 931 Programmes at the National and Acute Health Care Facility Level] . World Health Organization. Country 932 Office for Thailand Infection prevention and control during health care when novel coronavirus ( 934 nCoV) infection is suspected: interim guidance Asymptomatic cases in a 936 family cluster with SARS-CoV-2 infection Severe acute respiratory syndrome Coronaviruses post-SARS: update on replication and pathogenesis Importation and human-to-human transmission of a novel coronavirus in 943 Vietnam Gomersall, 945 C.D., 2020. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and 946 recommendations. The Lancet Respiratory Medicine Identification of severe acute respiratory syndrome in Canada Dipeptidyl peptidase 4 is a functional receptor for the emerging human 952 coronavirus-EMC Effects of chloroquine on viral 957 infections: an old drug against today's diseases. The Lancet infectious diseases Treatment 959 of 5 critically ill patients with COVID-19 with convalescent plasma 961 Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike 962 glycoprotein-mediated viral entry COVID-19 drug therapy Ultrastructure and origin of membrane vesicles associated with the 966 severe acute respiratory syndrome coronavirus replication complex Lack of peripheral memory B cell responses in recovered patients with severe acute 969 respiratory syndrome: a six-year follow-up study Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to 972 severe acute respiratory syndrome coronavirus infection Chloroquine is a potent inhibitor of SARS coronavirus infection and spread 977 Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in 978 Wuhan Description of COVID-19 cases along with the measures 980 taken on prevention and control in Zhejiang SARS coronavirus entry into 982 host cells through a novel clathrin-and caveolae-independent endocytic pathway Remdesivir and chloroquine effectively inhibit the recently emerged novel 984 coronavirus (2019 nCoV) in vitro Precautions in ophthalmic practice in the prevention and control of the 986 novel coronavirus pneumonia epidemic Human-leukocyte antigen class I Cw 1502 and class II DR 0301 genotypes are associated 990 with resistance to severe acute respiratory syndrome (SARS) infection Updated understanding of the outbreak of Detection of SARS-CoV-2 in different 994 types of clinical specimens Challenges to the system of reserve medical supplies for public health 996 emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus CoV-2) epidemic in China Presymptomatic 999 Transmission of SARS-CoV-2-Singapore The mercurial nature of neutrophils: 1001 still an enigma in ARDS? Virological assessment of hospitalized cases of coronavirus 1003 disease Risk 1005 factors associated with acute respiratory distress syndrome and death in patients with coronavirus 1006 disease A new coronavirus associated with human respiratory disease in China Clinical characteristics of patients who died of 1010 coronavirus disease 2019 in China Effect treatment of severe COVID-19 patients with tocilizumab m., 2020b. 1014 Pathological findings of COVID-19 associated with acute respiratory distress syndrome Chinese Academy of Medical Science, Peking Union Medical 1016 Peking Union Medical College Hospital, 100730; Effect of Alendronate on primary osteoporosis 1017 The structural 1019 and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus 1020 (MERS-CoV) are potent interferon antagonists A familial cluster of infection associated with the 2019 1022 novel coronavirus indicating possible person-to-person transmission during the incubation period Macrolides: 1025 from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory 1026 diseases infections, 2020. Molecular and serological investigation of 2019-nCoV infected patients: 1029 implication of multiple shedding routes Rapid generation of a mouse model for Middle East respiratory 1032 syndrome 1034 Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China Recommendations and guidance for 1037 providing pharmaceutical care services during COVID-19 pandemic: a China perspective Clinical course 1040 and risk factors for mortality of adult inpatients with COVID-19 in Wuhan Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus 1044 pneumonia: protocol of a randomized controlled trial Coronaviruses-drug discovery and 1046 therapeutic options J o u r n a l P r e -p r o o f Highlights:• The rate of COVID-19 transmission is declined by isolation and disinfectant products.• Reduction of this disease is favored by clinical controlled strategies.• There is a positive relationship between antiviral drugs and immunotherapies against the infection.• Pharmaceutical frontlines are responsible to show a great impact on human health concerns. ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f